Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Potential for health care cost savings with preoperative gastrostomy tube placement in the head and neck cancer population.

Mays AC, Bartels HG, Wistermayer PR, Rohlfing ML, Gentile CM, D'Agostino R Jr, Waltonen JD.

Head Neck. 2018 Jan;40(1):111-119. doi: 10.1002/hed.24992. Epub 2017 Nov 13.

PMID:
29131450
2.

Anatomical Variations of the Transverse-Sigmoid Sinus Junction: Implications for Endovascular Treatment of Idiopathic Intracranial Hypertension.

McCormick MW, Bartels HG, Rodriguez A, Johnson JE, Janjua RM.

Anat Rec (Hoboken). 2016 Aug;299(8):1037-42. doi: 10.1002/ar.23370. Epub 2016 May 24.

3.

High Proportion of Nuclear Phenotype Identifies Aggressive Cutaneous Squamous Cell Carcinoma.

Glazer ES, Bartels PH, Liang J, Prasad AR, Yozwiak ML, Krutzsch M, Clark C, Kha S, Bartels HG, Einspahr JG, Alberts DS, Krouse RS.

Anal Quant Cytopathol Histpathol. 2015 Oct;37(5):302-9.

PMID:
26856115
4.

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases.

Glazer ES, Bartels PH, Lian F, Kha ST, Morgan SS, da Silva VD, Yozwiak ML, Bartels HG, Cranmer LD, de Oliveira JK, Alberts DS, Warneke JA, Krouse RS.

Melanoma Res. 2016 Jun;26(3):261-6. doi: 10.1097/CMR.0000000000000236.

PMID:
26795273
5.

Phase IIB Randomized Study of Topical Difluoromethylornithine and Topical Diclofenac on Sun-Damaged Skin of the Forearm.

Jeter JM, Curiel-Lewandrowski C, Stratton SP, Myrdal PB, Warneke JA, Einspahr JG, Bartels HG, Yozwiak M, Bermudez Y, Hu C, Bartels P, Alberts DS.

Cancer Prev Res (Phila). 2016 Feb;9(2):128-34. doi: 10.1158/1940-6207.CAPR-15-0232. Epub 2015 Dec 28.

6.

Classification in karyometry: performance testing and prediction error.

Bartels PH, Bartels HG.

Anal Quant Cytopathol Histpathol. 2013 Aug;35(4):181-8.

7.

Policy coherence for improved medical innovation and access.

Mirza Z, Krattiger A, Taubman A, Bartels HG, Beyer P, Kampf R, Watal J.

Bull World Health Organ. 2013 May 1;91(5):315-315A. doi: 10.2471/BLT.13.122705. No abstract available.

8.

Karyometry of nuclear phenotypes in cutaneous squamous cell cancer.

Bartels PH, Bartels HG, Alberts DS, Yozwiak M, Prasad AR, Glazer ES, Krouse RS.

Anal Quant Cytol Histol. 2012 Feb;34(1):1-8.

9.

Karyometry in atypical endometrial hyperplasia: a Gynecologic Oncology Group study.

Bartels PH, Garcia FA, Trimble CL, Kauderer J, Curtin J, Lim PC, Hess LM, Silverberg S, Zaino RJ, Yozwiak M, Bartels HG, Alberts DS.

Gynecol Oncol. 2012 Apr;125(1):129-35. doi: 10.1016/j.ygyno.2011.12.422. Epub 2011 Dec 9.

10.

A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry.

Montironi R, Bartels PH, DeCensi A, Puntoni M, Hurle R, Decobelli O, Carmignani G, Mazzucchelli R, Bartels HG, Alberts DS, Maffezzini M.

Urol Oncol. 2013 Jul;31(5):557-65. doi: 10.1016/j.urolonc.2011.02.024. Epub 2011 Jul 23.

PMID:
21783387
11.

Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma.

Glazer ES, Bartels PH, Prasad AR, Yozwiak ML, Bartels HG, Einspahr JG, Alberts DS, Krouse RS.

Cancer Prev Res (Phila). 2011 Nov;4(11):1770-7. doi: 10.1158/1940-6207.CAPR-10-0404. Epub 2011 Jun 2.

12.

Discriminant analysis.

Bartels PH, Bartels HG.

Anal Quant Cytol Histol. 2009 Oct;31(5):247-54.

PMID:
20701090
13.

Knowledge discovery processing and data mining in karyometry.

Bartels PH, Montironi R, Scarpelli M, Bartels HG, Alberts DS.

Anal Quant Cytol Histol. 2009 Jun;31(3):125-36.

14.

Karyometry: correction algorithm for differences in staining.

Bartels PH, Bartels HG, Alberts DS.

Anal Quant Cytol Histol. 2009 Apr;31(2):63-73.

15.

Progression of skin lesions from normal skin to squamous cell carcinoma.

Krouse RS, Alberts DS, Prasad AR, Yozwiak M, Bartels HG, Liu Y, Bartels PH.

Anal Quant Cytol Histol. 2009 Feb;31(1):17-25.

16.

Actinic damage in histopathologically normal skin.

Bartels PH, Krouse RS, Prasad AR, Yozwiak M, Liu Y, Bartels HG, Alberts DS.

Anal Quant Cytol Histol. 2008 Dec;30(6):316-22.

17.

Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months.

Frank DH, Kimler BF, Fabian CJ, Ranger-Moore J, Yozwiak M, Bartels HG, Alberts DS, Bartels PH.

Breast Cancer Res Treat. 2009 Jun;115(3):661-8. doi: 10.1007/s10549-008-0274-0. Epub 2009 Jan 6.

PMID:
19125322
18.

Limits of detection of chemopreventive efficacy: karyometry of skin biopsies.

Bartels PH, Yozwiak ML, Bartels HG, Liu Y, Hess LM, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1689-95. doi: 10.1158/1055-9965.EPI-08-0313. Epub 2008 Jun 26.

19.

Karyometry of the colonic mucosa.

Alberts DS, Einspahr JG, Krouse RS, Prasad A, Ranger-Moore J, Hamilton P, Ismail A, Lance P, Goldschmid S, Hess LM, Yozwiak M, Bartels HG, Bartels PH.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2704-16.

20.

Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential.

Montironi R, Scarpelli M, Lopez-Beltran A, Mazzucchelli R, Alberts D, Ranger-Moore J, Bartels HG, Hamilton PW, Einspahr J, Bartels PH.

Cell Oncol. 2007;29(1):47-58.

21.

Karyometry of infiltrating breast lesions.

Frank DH, Davis JR, Ranger-Moore J, Liu Y, Bartels HG, Alberts DS, Bartels PH.

Anal Quant Cytol Histol. 2005 Aug;27(4):195-201.

PMID:
16220830
22.

Karyometry in rectal mucosa of patients with previous colorectal adenomas.

Ranger-Moore J, Frank D, Lance P, Alberts D, Yozwiak M, Bartels HG, Einspahr J, Bartels PH.

Anal Quant Cytol Histol. 2005 Jun;27(3):134-42.

PMID:
16121634
23.

Karyometry in the early detection and chemoprevention of intraepithelial lesions.

Ranger-Moore J, Alberts DS, Montironi R, Garcia F, Davis J, Frank D, Brewer M, Mariuzzi GM, Bartels HG, Bartels PH.

Eur J Cancer. 2005 Sep;41(13):1875-88.

PMID:
16087328
24.

Second order discriminant analysis in chemopreventive efficacy measurement.

Bartels PH, Ranger-Moore J, Bartels HG, Alberts DS.

Anal Quant Cytol Histol. 2005 Feb;27(1):15-26.

PMID:
15794448
25.

Preneoplastic changes in ovarian tissues.

Brewer MA, Ranger-Moore J, Greene MH, Alberts DS, Liu Y, Bartels HG, Baruch AC, Bartels PH.

Anal Quant Cytol Histol. 2004 Aug;26(4):207-16.

PMID:
15457673
26.

Karyometric image analysis for intraepithelial and invasive cervical lesions.

Garcia FA, Ranger-Moore J, Barker B, Davis J, Brewer M, Lozevski J, Vinyak S, Liu Y, Yemane J, Hatch KD, Alberts DS, Bartels HG, Bartels PH.

Anal Quant Cytol Histol. 2004 Jun;26(3):141-50.

PMID:
15218690
27.

Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia.

Montironi R, Thompson D, Scarpelli M, Bartels HG, Hamilton PW, da Silva VD, Sakr WA, Weyn B, van Daele A, Bartels PH.

J Clin Pathol. 2002 Jun;55(6):452-60.

28.

Quantitative study of ductal breast cancer progression: nuclear signatures for evaluation of progression grade.

Mombello A, Mariuzzi L, Morelli L, Granchelli G, Rucco V, Tarocco E, da Silva VD, Thompson D, Bartels HG, Bartels PH, Mariuzzi G.

Adv Clin Path. 2001 Jul;5(3):59-70.

PMID:
11753877
29.

Karyometry of secretory cell nuclei in high-grade PIN lesions.

Bartels PH, Montironi RM, Bostwick D, Marshall J, Thompson D, Bartels HG, Kelley D.

Prostate. 2001 Aug 1;48(3):144-55.

PMID:
11494330
30.

Progression curves for endometrial lesions.

Bartels PH, Garcia FA, Davis J, da Silva VD, Bartels HG, Thompson D, Alberts DS.

Anal Quant Cytol Histol. 2001 Feb;23(1):1-8.

PMID:
11233737
31.

Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer.

Mariuzzi L, Mombello A, Rucco V, Morelli L, Zamò A, Thompson D, Vaught L, Bartels HG, Mariuzzi G, Bartels PH.

Adv Clin Path. 2000 Apr;4(2):87-97.

PMID:
11080789
32.

Data representation and reduction for chromatin texture in nuclei from premalignant prostatic, esophageal, and colonic lesions.

Weyn B, Jacob W, da Silva VD, Montironi R, Hamilton PW, Thompson D, Bartels HG, Van Daele A, Dillon K, Bartels PH.

Cytometry. 2000 Oct 1;41(2):133-8.

PMID:
11002269
33.

Chromatin texture in high grade prostatic intraepithelial neoplasia and early invasive carcinoma.

da Silva VD, Montironi R, Thompson D, Bartels HG, Vaught L, Hamilton PW, Bartels PH.

Anal Quant Cytol Histol. 1999 Apr;21(2):113-20.

PMID:
10560478
34.

Tissue architecture analysis in prostate cancer and its precursors: An innovative approach to computerized histometry.

Bartels PH, Montironi R, Duval da Silva V, Hamilton PW, Thompson D, Vaught L, Bartels HG.

Eur Urol. 1999;35(5-6):484-91. Review.

PMID:
10325510
35.

Chromatin texture signatures in nuclei from prostate lesions.

Bartels PH, da Silva VD, Montironi R, Hamilton PW, Thompson D, Vaught L, Bartels HG.

Anal Quant Cytol Histol. 1998 Oct;20(5):407-16.

PMID:
9801759
36.

Nuclear chromatin texture in prostatic lesions. II. PIN and malignancy associated changes.

Bartels PH, Montironi R, Hamilton PW, Thompson D, Vaught L, Bartels HG.

Anal Quant Cytol Histol. 1998 Oct;20(5):397-406.

PMID:
9801758
37.

Nuclear chromatin texture in prostatic lesions. I. PIN and adenocarcinoma.

Bartels PH, Montironi R, Hamilton PW, Thompson D, Vaught L, Bartels HG.

Anal Quant Cytol Histol. 1998 Oct;20(5):389-96.

PMID:
9801757
38.

Machine vision in the detection of prostate lesions in histologic sections.

Bartels PH, Bartels HG, Montironi R, Hamilton PW, Thompson D.

Anal Quant Cytol Histol. 1998 Oct;20(5):358-64.

PMID:
9801753
39.

Knowledge-guided histometry of the basal cell layer in prostatic intraepithelial neoplasia.

Thompson D, Bartels PH, Bartels HG, Montironi R.

Anal Quant Cytol Histol. 1996 Apr;18(2):177-84.

PMID:
8744508
40.

Analysis of the capillary architecture in the precursors of prostate cancer: recent findings and new concepts.

Montironi R, Diamanti L, Thompson D, Bartels HG, Bartels PH.

Eur Urol. 1996;30(2):191-200. Review.

PMID:
8875200
41.

Image segmentation of cribriform gland tissue.

Thompson D, Bartels PH, Bartels HG, Montironi R.

Anal Quant Cytol Histol. 1995 Oct;17(5):314-22.

PMID:
8534334
42.

Machine vision-based histometry of premalignant and malignant prostatic lesions.

Bartels PH, Thompson D, Bartels HG, Montironi R, Scarpelli M, Hamilton PW.

Pathol Res Pract. 1995 Sep;191(9):935-44.

PMID:
8606876
43.

Prostatic intraepithelial neoplasia. Quantitation of the basal cell layer with machine vision system.

Montironi R, Bartels PH, Thompson D, Bartels HG, Scarpelli M.

Pathol Res Pract. 1995 Sep;191(9):917-23.

PMID:
8606874
44.

Knowledge-guided segmentation of colorectal histopathologic imagery.

Thompson D, Bartels PH, Bartels HG, Hamilton PW, Sloan JM.

Anal Quant Cytol Histol. 1993 Aug;15(4):236-46.

PMID:
7691061
45.

Tissue architectural features for the grading of prostatic carcinoma.

Bibbo M, Kim DH, di Loreto C, Dytch HE, Galera-Davidson H, Thompson D, Richards DL, Bartels HG, Bartels PH.

Anal Quant Cytol Histol. 1990 Aug;12(4):229-36.

PMID:
2206192
46.

Machine vision system for diagnostic histopathology.

Bartels PH, Thompson D, Bartels HG, Shoemaker R.

Pathol Res Pract. 1989 Nov;185(5):635-46.

PMID:
2626374
47.

Discrimination of DNA ploidy patterns by order statistics.

Weber JE, Bartels PH, Bartels HG, Bibbo M.

Anal Quant Cytol Histol. 1987 Mar;9(1):60-8.

PMID:
3580085
48.

Stabilized binary hierarchic classifier in cytopathologic diagnosis.

Bartels HG, Bartels PH, Bibbo M, Wied GL.

Anal Quant Cytol. 1984 Dec;6(4):247-61.

PMID:
6397084
49.

The automated analytical electrophoresis microscope.

Bartels PH, Olson GB, Bartels HG, Brooks DE, Seaman GV.

Cell Biophys. 1981 Dec;3(4):371-86.

PMID:
6175421

Supplemental Content

Loading ...
Support Center